These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 12233717

  • 1. Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease.
    Brandy RC, Schleiss MR, Witte DP, Siddiqi TA, Fame PT.
    Pediatr Infect Dis J; 2002 Aug; 21(8):796-7. PubMed ID: 12233717
    [Abstract] [Full Text] [Related]

  • 2. [Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
    Sola E, Vega E, Gutiérrez C, López V, Cabello M, Burgos D, González Molina M, Siles J.
    Nefrologia; 2009 Aug; 29(2):180-1. PubMed ID: 19396331
    [No Abstract] [Full Text] [Related]

  • 3. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R, Mastroianni A, Coronado OV, Chiodo F.
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [Abstract] [Full Text] [Related]

  • 4. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA, Drew WL, Feinberg J, O'Donnell JJ, Whitmore PV, Miner RD, Parenti D.
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [Abstract] [Full Text] [Related]

  • 5. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
    [Abstract] [Full Text] [Related]

  • 6. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ, Valganciclovir Study Group.
    N Engl J Med; 2002 Apr 11; 346(15):1119-26. PubMed ID: 11948271
    [Abstract] [Full Text] [Related]

  • 7. Foscarnet for CMV retinitis.
    Wood CA.
    Lancet; 1992 Feb 22; 339(8791):501. PubMed ID: 1346861
    [No Abstract] [Full Text] [Related]

  • 8. Failure of adjunctive cytomegalovirus intravenous immune globulin to improve efficacy of ganciclovir in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: a phase 1 study.
    Jacobson MA, O'Donnell JJ, Rousell R, Dionian B, Mills J.
    Antimicrob Agents Chemother; 1990 Jan 22; 34(1):176-8. PubMed ID: 2158273
    [Abstract] [Full Text] [Related]

  • 9. Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Spector SA.
    J Int Assoc Physicians AIDS Care; 1996 May 22; 2(5):9-12, 15-22. PubMed ID: 11363539
    [Abstract] [Full Text] [Related]

  • 10. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
    Duker JS, Robinson M, Anand R, Ashton P.
    Ophthalmic Surg Lasers; 1995 May 22; 26(5):442-8. PubMed ID: 8963859
    [Abstract] [Full Text] [Related]

  • 11. Treatment of CMV retinitis.
    Bachman DM.
    N Engl J Med; 1992 Jun 18; 326(25):1702; author reply 1702-3. PubMed ID: 1317012
    [No Abstract] [Full Text] [Related]

  • 12. Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus.
    Laskin OL, Cederberg DM, Mills J, Eron LJ, Mildvan D, Spector SA.
    Am J Med; 1987 Aug 18; 83(2):201-7. PubMed ID: 3039841
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis.
    Besbas N, Bayrakci US, Kale G, Cengiz AB, Akcoren Z, Akinci D, Kilic I, Bakkaloglu A.
    Pediatr Nephrol; 2006 May 18; 21(5):740-2. PubMed ID: 16523262
    [Abstract] [Full Text] [Related]

  • 14. Development of cytomegalovirus (CMV) retinitis in a patient with AIDS during ganciclovir therapy for CMV colitis.
    O'Donnell JJ, Jacobson MA, Mills J.
    N Engl J Med; 1987 Jun 18; 316(25):1607-8. PubMed ID: 3035374
    [No Abstract] [Full Text] [Related]

  • 15. Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir).
    Teich SA, Castle J, Friedman AH, Siroty W, Orellana J, Schmitterer M.
    Br J Ophthalmol; 1988 Apr 18; 72(4):293-8. PubMed ID: 2837272
    [Abstract] [Full Text] [Related]

  • 16. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).
    Orellana J, Teich SA, Winterkorn JS, Mathur-Wagh U, Handwerger S, Schlamm H, Malamud SC, Yancovitz SR, Cederberg DM, Mildvan DS.
    Br J Ophthalmol; 1988 Jul 18; 72(7):525-9. PubMed ID: 2843219
    [Abstract] [Full Text] [Related]

  • 17. Treatment of CMV retinitis.
    Deray G, Katlama C, Jacobs C.
    N Engl J Med; 1992 Jun 18; 326(25):1702. PubMed ID: 1317011
    [No Abstract] [Full Text] [Related]

  • 18. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML, Jacobson PA.
    Pharmacotherapy; 1992 Jun 18; 12(4):300-18. PubMed ID: 1325636
    [Abstract] [Full Text] [Related]

  • 19. [Valganciclovir maintenance therapy in AIDS: treatment failure due to the development of cytomegalovirus resistance to ganciclovir].
    Couzigou C, Mazeron MC, Escaut L, Merad M, Vittecoq D.
    Med Mal Infect; 2005 Feb 18; 35(2):98-100. PubMed ID: 15780901
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of CMV retinitis.
    Morris DJ.
    Lancet; 1992 Jan 25; 339(8787):247. PubMed ID: 1346202
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.